Welcome to our dedicated page for SEMPRA SEC filings (Ticker: SRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SEMPRA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SEMPRA's regulatory disclosures and financial reporting.
Sempra director Andres Conesa received a grant of phantom shares as part of his director compensation. On this award date, he acquired 136.81 phantom shares linked to Sempra common stock, with a reference price of $91.37 per share and a 1-for-1 conversion ratio into common stock.
After this grant, Conesa holds a total of 11,731.81 phantom shares. Vested phantom shares are immediately exercisable, and the award has no stated expiration date. This is a routine, compensation-related equity award rather than an open-market stock purchase or sale.
Sempra Executive Vice President Caroline Ann Winn reported open-market sales of 8,000 shares of Sempra common stock on June 17, 2026. She sold 7,900 shares at a weighted average price of $90.56 and 100 shares at $89.85. After these sales, she directly holds 25,163.81 shares and indirectly holds 11,320.04 shares through a 401(k) savings plan as of June 16, 2026.
Sempra filed a Form 144 notice reporting proposed sales of Common Stock related to vested restricted stock units. The notice lists multiple vesting events: 10/15/2025 (42 shares), 01/02/2026 (4,308 shares), 01/15/2026 (31 shares), 01/27/2026 (2,361 shares), and 04/30/2026 (1,258 shares). These entries are described as vesting of equity awards or reinvested dividends from vested RSUs.
Sempra closed a public debt offering of $1,000,000,000 aggregate principal amount of its Floating Rate Notes due 2028. The notes were sold to underwriters for resale at a public offering price of 100.000% of principal, generating approximately $998.5 million in proceeds after underwriting discounts and before estimated offering expenses of about $1.7 million.
The notes bear interest at a floating rate equal to Compounded SOFR plus 0.670% per year, with interest accruing from June 9, 2026 and payable quarterly on April 7, July 7, October 7 and January 7, starting October 7, 2026. The notes mature on January 7, 2028 and are not redeemable at Sempra’s option before maturity. They were issued under Sempra’s existing shelf registration statement and an indenture dated February 23, 2000.
Sempra is offering $1,000,000,000 aggregate principal amount of Floating Rate Notes due 2028. The notes pay an annual rate equal to Compounded SOFR plus 67 basis points, accrue interest from June 9, 2026 and mature on January 7, 2028. Interest is payable quarterly beginning October 7, 2026. The notes are unsecured, unsubordinated obligations, not redeemable prior to maturity and will not be listed on any exchange.
Net proceeds are estimated at approximately $998.5 million (before expenses). Sempra intends to use a substantial portion of the proceeds to repay outstanding commercial paper and potentially other indebtedness, and to apply remaining net proceeds to general corporate purposes.
Sempra is offering Floating Rate Notes due 2028. The notes mature on January 7, 2028 and will bear interest at Compounded SOFR plus a Margin, payable quarterly beginning on October 7, 2026. The notes are unsecured, unsubordinated senior obligations and will rank equally with Sempra’s other unsecured indebtedness.
The prospectus supplement describes SOFR-based interest calculation using the SOFR Index, Benchmark Transition Event provisions that permit replacement of Compounded SOFR and related Benchmark Replacement Conforming Changes, and customary U.S. federal tax, underwriting and risk-factor disclosures. A substantial portion of net proceeds is intended to repay commercial paper and other indebtedness; estimated offering expenses are $1.7 million.
Sempra director Pablo Ferrero reported an open-market sale of 2,600 shares of Sempra common stock at $89.53 per share. This Form 4 filing shows that after the transaction, he directly holds 15,423.32 shares, indicating he sold only a portion of his existing stake.
Sempra filed a shelf registration and prospectus supplement to offer up to $3,000,000,000 of common stock, available from time to time after the effective date. The offering is structured under an ATM Equity Offering Sales Agreement with multiple agents and forward purchasers.
The prospectus supplement states that Sempra has previously sold $415,591,197 in aggregate gross sales under the agreement and that approximately $2,584,408,803 of capacity remains available for future sales. Sales may be made on the NYSE, in negotiated transactions, block trades, or "at-the-market" transactions through the agents or forward sellers, and proceeds treatment varies with the settlement method described in the supplement.
Sempra Chief Legal Counsel Diana L. Day reported an open-market sale of 3,300 shares of common stock at $92.13 per share. The transaction was executed under a pre-established Rule 10b5-1(c) trading plan adopted on May 20, 2024. Following the sale, she directly holds 22,869.79 common shares and indirectly holds 418.6 shares through a 401(k) Savings Plan as of May 14, 2026. The filing also notes that her post-transaction beneficial ownership corrects a prior overstatement of 342 shares due to a clerical error.